Cargando…
Holding our breath: the promise of tissue-resident memory T cells in lung cancer
T cell memory is critical in controlling infection and plays an important role in anti-tumor responses in solid cancers. While effector memory and central memory T cells circulate and patrol non-lymphoid and lymphoid organs respectively, tissue resident memory T cells (T(RM)) permanently reside in t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264348/ https://www.ncbi.nlm.nih.gov/pubmed/34295680 http://dx.doi.org/10.21037/tlcr-20-819 |
Sumario: | T cell memory is critical in controlling infection and plays an important role in anti-tumor responses in solid cancers. While effector memory and central memory T cells circulate and patrol non-lymphoid and lymphoid organs respectively, tissue resident memory T cells (T(RM)) permanently reside in tissues and provide local protective immune responses. In a number of solid tumors, tumor-specific T cell memory responses likely play an important role in keeping tumors in check, limiting cancer cell dissemination and reducing risk of relapse. In non-small cell lung cancer (NSCLC), a subset of tumor infiltrating lymphocytes (TILs) display phenotypic and functional characteristics associated with lung T(RM) (T(RM)-like TILs), including the expression of tissue-specific homing molecules and immune exhaustion markers. High infiltration of T(RM)-like TILs correlates with better survival outcomes for lung cancer patients, indicating that T(RM)-like TILs may contribute to anti-tumor responses. However, a number of T(RM)-like TILs do not display tumor specificity and the exact role of T(RM)-like TILs in mediating anti-tumor response in lung cancer is unclear. Here we review the characteristics of T(RM)-like TILs in lung cancer, the role these cells play in mediating anti-tumor immunity and the therapeutic implications of T(RM)-like TILs in the use and development of immunotherapy for lung cancer. |
---|